Halozyme Therapeutics, Inc. (HALO)

66.35 +0.48 (+0.73%) USD  |  NASDAQ  |  May 06, 16:00
67.13 +0.78 (+1.18%) Pre-Market: 20:00
More

Halozyme Therapeutics Annual Revenue Estimates

Annual Revenue Estimates Chart

View Annual Revenue Estimates for HALO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Annual Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Annual Revenue Estimates Range, Past 5 Years

View Annual Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Annual Revenue Estimates Benchmarks

View Annual Revenue Estimates Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. Upgrade
Eli Lilly & Co. Upgrade
Johnson & Johnson Upgrade
Baxter International, Inc. Upgrade
Glaukos Corp. Upgrade